CHGCY vs. WEBNF
Compare and contrast key facts about Chugai Pharmaceutical Co Ltd ADR (CHGCY) and Westpac Banking Corp (WEBNF).
Performance
CHGCY vs. WEBNF - Performance Comparison
Loading graphics...
CHGCY vs. WEBNF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CHGCY Chugai Pharmaceutical Co Ltd ADR | 11.42% | 21.53% | 17.55% | 48.78% | -21.63% | -38.50% | 72.01% | 59.87% | 13.53% | 72.59% |
WEBNF Westpac Banking Corp | 6.36% | 39.75% | 34.48% | 5.37% | 10.13% | 52.61% | -8.36% | 6.69% | -16.10% | 23.08% |
Fundamentals
CHGCY:
$96.34B
WEBNF:
$65.19B
CHGCY:
$138.25
WEBNF:
$5.20
CHGCY:
0.21
WEBNF:
5.14
CHGCY:
0.08
WEBNF:
1.29
CHGCY:
0.05
WEBNF:
1.36
CHGCY:
$1.27T
WEBNF:
$50.58B
CHGCY:
$937.60B
WEBNF:
$77.69B
CHGCY:
$661.98B
WEBNF:
$3.05B
Returns By Period
In the year-to-date period, CHGCY achieves a 11.42% return, which is significantly higher than WEBNF's 6.36% return. Over the past 10 years, CHGCY has outperformed WEBNF with an annualized return of 19.94%, while WEBNF has yielded a comparatively lower 13.89% annualized return.
CHGCY
- 1D
- 6.36%
- 1M
- -9.01%
- YTD
- 11.42%
- 6M
- 26.71%
- 1Y
- 31.64%
- 3Y*
- 34.69%
- 5Y*
- 8.26%
- 10Y*
- 19.94%
WEBNF
- 1D
- -6.79%
- 1M
- -10.39%
- YTD
- 6.36%
- 6M
- 9.49%
- 1Y
- 48.24%
- 3Y*
- 32.09%
- 5Y*
- 22.16%
- 10Y*
- 13.89%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CHGCY vs. WEBNF — Risk / Return Rank
CHGCY
WEBNF
CHGCY vs. WEBNF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Chugai Pharmaceutical Co Ltd ADR (CHGCY) and Westpac Banking Corp (WEBNF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CHGCY | WEBNF | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.69 | 0.86 | -0.17 |
Sortino ratioReturn per unit of downside risk | 1.24 | 1.52 | -0.28 |
Omega ratioGain probability vs. loss probability | 1.17 | 1.22 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 0.95 | 2.15 | -1.20 |
Martin ratioReturn relative to average drawdown | 1.87 | 6.70 | -4.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CHGCY | WEBNF | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.69 | 0.86 | -0.17 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.25 | 0.52 | -0.27 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 0.36 | +0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.58 | 0.19 | +0.39 |
Correlation
The correlation between CHGCY and WEBNF is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CHGCY vs. WEBNF - Dividend Comparison
CHGCY's dividend yield for the trailing twelve months is around 1.45%, less than WEBNF's 2.61% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHGCY Chugai Pharmaceutical Co Ltd ADR | 1.45% | 1.62% | 0.86% | 0.00% | 1.19% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.64% | 1.41% |
WEBNF Westpac Banking Corp | 2.61% | 2.78% | 8.39% | 8.91% | 7.82% | 42.62% | 3.83% | 14.51% | 19.31% | 16.01% | 0.00% | 0.00% |
Drawdowns
CHGCY vs. WEBNF - Drawdown Comparison
The maximum CHGCY drawdown since its inception was -59.68%, smaller than the maximum WEBNF drawdown of -66.96%. Use the drawdown chart below to compare losses from any high point for CHGCY and WEBNF.
Loading graphics...
Drawdown Indicators
| CHGCY | WEBNF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.68% | -66.96% | +7.28% |
Max Drawdown (1Y)Largest decline over 1 year | -32.48% | -18.99% | -13.49% |
Max Drawdown (5Y)Largest decline over 5 years | -45.45% | -31.26% | -14.19% |
Max Drawdown (10Y)Largest decline over 10 years | -59.68% | -61.21% | +1.53% |
Current DrawdownCurrent decline from peak | -12.91% | -12.50% | -0.41% |
Average DrawdownAverage peak-to-trough decline | -16.00% | -21.11% | +5.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.49% | 6.09% | +10.40% |
Volatility
CHGCY vs. WEBNF - Volatility Comparison
Chugai Pharmaceutical Co Ltd ADR (CHGCY) has a higher volatility of 12.49% compared to Westpac Banking Corp (WEBNF) at 11.28%. This indicates that CHGCY's price experiences larger fluctuations and is considered to be riskier than WEBNF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CHGCY | WEBNF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.49% | 11.28% | +1.21% |
Volatility (6M)Calculated over the trailing 6-month period | 26.89% | 31.69% | -4.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.96% | 56.65% | -10.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.36% | 42.67% | -9.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.31% | 39.13% | -6.82% |
Financials
CHGCY vs. WEBNF - Financials Comparison
This section allows you to compare key financial metrics between Chugai Pharmaceutical Co Ltd ADR and Westpac Banking Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CHGCY vs. WEBNF - Profitability Comparison
CHGCY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Chugai Pharmaceutical Co Ltd ADR reported a gross profit of 298.03B and revenue of 352.55B. Therefore, the gross margin over that period was 84.5%.
WEBNF - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Westpac Banking Corp reported a gross profit of 0.00 and revenue of 18.98B. Therefore, the gross margin over that period was 0.0%.
CHGCY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Chugai Pharmaceutical Co Ltd ADR reported an operating income of 172.47B and revenue of 352.55B, resulting in an operating margin of 48.9%.
WEBNF - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Westpac Banking Corp reported an operating income of 1.16B and revenue of 18.98B, resulting in an operating margin of 6.1%.
CHGCY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Chugai Pharmaceutical Co Ltd ADR reported a net income of 147.51B and revenue of 352.55B, resulting in a net margin of 41.8%.
WEBNF - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Westpac Banking Corp reported a net income of 2.38B and revenue of 18.98B, resulting in a net margin of 12.5%.